The U.S. Food and Drug Admininstration (FDA) has proposed a new risk-based enforcement approach to drugs labeled as homeopathic. Many homeopathic treatments are being marketed as remedies for serious diseases and conditions when there is no actual proof the products provide clinical benefits, FDA says. Certain homeopathic-labeled products do not...
According to an enforcement policy statement released, by the Federal Trade Commission (FTC) on November 15, 2016, the FTC will begin to hold over the counter (OTC) homeopathic makers to the same standards as other products that make similar claims of treating specific conditions. Under the new policy, claims “based...
